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Type VI secretion (T6S) influences the composition of
microbial communities by catalyzing the delivery of
toxins between adjacent bacterial cells. Here, we
demonstrate that a T6S integral membrane toxin
from Pseudomonas aeruginosa, Tse6, acts on target
cells by degrading the universally essential dinucleo-
tides NAD+ and NADP+. Structural analyses of Tse6
show that it resembles mono-ADP-ribosyltransfer-
ase proteins, such as diphtheria toxin, with the
exception of a unique loop that both excludes pro-
teinaceous ADP-ribose acceptors and contributes
to hydrolysis. We find that entry of Tse6 into target
cells requires its binding to an essential house-
keeping protein, translation elongation factor Tu
(EF-Tu). These proteins participate in a larger assem-
bly that additionally directs toxin export and provides
chaperone activity. Visualization of this complex by
electron microscopy defines the architecture of a
toxin-loaded T6S apparatus and provides mecha-
nistic insight into intercellular membrane protein de-
livery between bacteria.
INTRODUCTION
Bacteria utilize a diverse group of secreted toxins to establish
and defend their niche. Among these are the effectors exported
by the type VI secretion system (T6SS), which are delivered to
target cells in a contact-dependent manner (Hood et al., 2010;
LeRoux et al., 2012; Russell et al., 2011). Despite the tremendous
number and predicted diversity of T6 effectors, few activities
have been ascribed to this important group of proteins.
The majority of characterized T6 effectors act in the periplasm
of target Gram-negative cells. Within this compartment, the pro-
teins disrupt essential structures, such as cell-wall peptido-
glycan (via amidase and glycoside hydrolase activity), and
cellular membranes (via phospholipase and pore-forming activ-
ity) (Russell et al., 2014). Although a large number of cytotoxic T6effectors have been identified, themechanisms bywhich they in-
fluence recipient cells are not well understood (Fritsch et al.,
2013; Hood et al., 2010; Whitney et al., 2014). Indeed, a group
of related effectors that exhibit DNase activity are the only
such proteins yet characterized (Ma et al., 2014).
Unlike other proteinaceous toxins, such as the colicins, T6S
effectors do not possess cell-entry mechanisms. Rather, they
transit the T6SS, which breaches the outer membrane of recip-
ient cells and thereby grants its substrates access to the cell inte-
rior (Russell et al., 2011). Many components of the T6SS bear
structural and functional relatedness to tail proteins of contractile
bacteriophage (Silverman et al., 2012). The delivery of T6 effec-
tors into recipient cells has not been directly visualized; however,
it is likely that they are propelled into recipient cells during
phage-like contraction events of the apparatus (Basler et al.,
2012). How T6 effectors are recruited to the secretory apparatus
is not completely understood. Evidence suggests at least two
genetically distinct mechanisms operate. One subset of T6 ef-
fectors requires direct interaction with the interior of ring-shaped
phage tail tube-like haemolysin co-regulated proteins (Hcp) for
export (Silverman et al., 2013). Hcp proteins themselves are
abundantly secreted in a T6-dependent manner, leading to the
proposal that these toxins are delivered to recipient cells in com-
plex with Hcp. The relatively low molecular weight of Hcp-asso-
ciated effectors suggests that interaction with the pore of Hcp
places constraints on the size of toxins that can be delivered
via this pathway.
A second subset of effectors, includingmany that are high-mo-
lecular-weight, multi-domain proteins, require specific valine-
glycine repeat protein G (VgrG) type proteins for export (Hachani
et al., 2014; Whitney et al., 2014). VgrG proteins form homotri-
meric assemblies that have extensive structural homology with
phage tail spike proteins, and, like Hcp, are secreted in a T6-
dependent manner. Also analogous to Hcp, the requirement for
VgrG proteins in effector export is thought to reflect a physical as-
sociation of these proteins with cognate effectors. The biochem-
ical basis for VgrG-effector interaction is not well studied; howev-
er, modular adaptor domains—present either as domains within
the effector protein or as independent polypeptides—appear to
mediate binding. One such domain harbors PAAR repeat se-
quences, which fold into a pyramidal structure that interactsCell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc. 607
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Figure 1. Tse6 Causes Stasis from the Cytoplasm of P. aeruginosa
(A) Genomic context of vgrG1, tsi6, tse6, and eagT6 in P. aeruginosa PAO1.
Locus tag numbers are provided below each gene. The color of each gene
corresponds to the color of its encoded protein shown in subsequent figures.
(B) Domain organization of P. aeruginosa Tse6. The boundaries for the PAAR
(residues 64–175) and toxin (residues 282–430) domains are indicated. Pre-
dicted transmembrane domains are shown as dark gray rectangles.
(C) Intoxication of P. aeruginosa by Tse6 severely reduces growth. Data
were derived from single-cell analysis of a parental strain (DretS DsspB
pPSV38::sspB) and a derivative depleted of Tsi6 (DretS DsspB tsi6-D4
pPSV38::sspB). Bin size is 20 min and is normalized to total cells (parental, n =
15,042; tsi6–D4, n = 5,568).
(D) Tsi6 depletion strains undergo Tse6-based toxicity independent of inter-
cellular toxin delivery by a functional H1-T6SS. Patches of the indicated
P. aeruginosa strains grown for 24 hr at 37C under Tsi6 depletion-inducing
(+IPTG) or non-inducing (IPTG) conditions are shown. The parental strain is
the same as in (C).
See also Movies S1 and S2 and Tables S2 and S3.with the tip of the VgrG spike (Shneider et al., 2013). Despite
recent advances in our understanding of the mechanisms under-
lying T6S-dependent interbacterial interactions, the structure of a608 Cell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc.T6 effector in complex with a VgrG family protein has remained
elusive.
The genome of Pseudomonas aeruginosa encodes three
T6SSs; each mediate antagonistic interactions with contacting
Gram-negative bacterial cells (Hood et al., 2010; Jiang et al.,
2014; Russell et al., 2013). Themost extensively studied of these
is the Hcp secretion island I-encoded T6SS (H1-T6SS), which
delivers at least six effectors to recipients. Prior work estab-
lished that one of these, type VI secretion exported 6 (Tse6), is
a predicted transmembrane protein that contains a PAAR repeat
domain, is exported in a VgrG-dependent manner, and is active
in the cytoplasm of target cells (Whitney et al., 2014). Here, we
demonstrate that Tse6 intoxicates by depleting cells of the
related co-factors b-nicotinamide adenine dinucleotide (NAD+)
and NAD+ phosphate (NADP+), thereby simultaneously inhibit-
ing anabolic and catabolic processes required for homeostasis
and growth. We make the surprising discovery that Tse6 re-
quires interaction with translation elongation factor Tu for deliv-
ery into recipient cells and define the structural and biochemical
basis for interbacterial transfer of this membrane-associated
toxin.
RESULTS
Tse6 Is a Bacteriostatic Toxin
We previously found that Tse6 is an H1-T6SS-dependent anti-
bacterial effector that requires vgrG1 for intercellular delivery
(Whitney et al., 2014). We further demonstrated that the toxic ac-
tivity of Tse6 resides in its C terminus and can be neutralized by
expression of a cognate immunity protein, Tsi6 (Figures 1A and
1B). Additionally, sequence and structural prediction algorithms
identify a PAAR domain (Tse6PAAR) flanked by transmembrane
segments in the N terminus of the protein.
The toxin domain of Tse6 does not bear homology to charac-
terized proteins. The majority of studied antibacterial T6S effec-
tors act on structures that are important for cellular integrity
(Russell et al., 2014). Accordingly, intoxication by these effectors
promotes morphological changes and cell lysis (LeRoux et al.,
2012). We examined P. aeruginosa cells undergoing Tse6-based
intoxication via depletion of Tsi6. The H1-T6SS is quiescent in
monoculture, thus we performed this and subsequent experi-
ments in a background with activated expression of the system
(DretS) (LeRoux et al., 2015). Single-cell analyses showed Tse6-
intoxicated cells displayed a dramatic increase in division time,
but generally maintained their structural integrity (Figure 1C;
Movies S1 and S2). The markedly slower growth of these cells
was also apparent macroscopically; strains depleted of Tsi6
failed to form visible colonies after 24 hr of incubation (Figure 1D).
Depletion of Tsi6 from P. aeruginosa cells lacking H1-T6SS func-
tion (DtssM1), and thus the capacity to transport effectors inter-
cellularly, yielded indistinguishable effects, indicating that the
toxin domain of Tse6 accesses the cytoplasm of donor cells prior
to export.
Tse6 Resembles Mono-ADP-Ribosyltransferase Toxins
To gain further insight into Tse6 function, we determined the
1.4 A˚ resolution crystal structure of its C-terminal toxin domain
(residues 282–430, Tse6282-CT) in complex with Tsi6 (Figure 2A;
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Figure 2. The Toxin Domain of Tse6 Adopts
a mART Fold and Harbors a Putative NAD+
Binding Site
(A) Overall structure of the Tse6282-CT –Tsi6 com-
plex. Tse6282-CT is shown in ribbon (left) and
space-filling (right) representations. Secondary
structure elements are labeled. Dots denote a
disordered segment (amino acids 400-408) of
Tse6282-CT that was not modeled.
(B) Tse6282-CT resembles mART toxins. Structural
alignment of Tse6282-CT with the catalytic domain
of diphtheria toxin (PDB: 4AE1). Inset shows a
structural alignment of the three conserved NAD+
binding residues (circled numbers) of diphtheria
toxin and Tse6. The numbers correspond to amino
acid positions within Tse6.
(C) Tsi6 interacts with the putative NAD+ binding
pocket of Tse6. Structural alignment of free Tsi6
and Tsi6 bound to Tse6282-CT. The structure of Tsi6
does not change significantly upon complex for-
mation (e.g., Glu63), except for Lys62, which ro-
tates 120 and interacts with Gln413 of Tse6.
See also Figure S1 and Tables S1–S3.Table S1). Importantly, expression of Tse6282-CT alone induced
stasis in Escherichia coli, recapitulating the phenotype of the
full-length toxin in P. aeruginosa (Figure S1A). Tse6282-CT adopts
amixed a/b fold comprised of twoN-terminal a helices and a cen-
tral core that is formed by two perpendicularly oriented b sheets
(Figure 2A). A search of the PDB using DALI indicated that the
closest structural homologs of Tse6282-CT are the catalytic do-
mains of bacterial mono-ADP-ribosyltransferase (mART) toxins
(Holm and Rosenstro¨m, 2010; Simon et al., 2014). Identified
members of this family include diphtheria toxin (DT) fromCoryne-
bacterium diphtheriae (Z score, 4.7; Ca root-mean-square devia-
tion [RMSD] of 4.3 A˚ over 87 equivalent positions) and Exotoxin A
(ExoA) fromP. aeruginosa (Z score, 3.0; CaRMSDof 2.8 A˚ over 73
equivalent positions). These and other characterized bacterial
mART enzymes are secreted virulence factors that transfer the
ADP-ribose moiety of NAD+ onto eukaryotic proteins, typically
leading to target protein inactivation, dramatic changes in cellular
physiology, and, often, cell death (Simon et al., 2014).
Despite a high degree of sequence divergence within mART
proteins, they possess a structurally conserved b sheet core
that harbors the molecular determinants for NAD+ binding (Field-
house et al., 2010; Zhang et al., 2014). Structural alignment of
Tse6282-CT with DT shows that peripheral secondary structure el-
ements differ significantly, while the two b sheets that comprise
the core overlay well (Figure 2B). Characterized mART enzymes
are subdivided into two main groups based on the identities of
amino acid residues at three positions involved in NAD+ binding
(Fieldhouse andMerrill, 2008). Members of the DT group useHis,
Tyr, and Glu, whereas Cholera toxin-type (CT) proteins retain Glu
at position 3, but use Arg and Ser at positions 1 and 2, respec-
tively. Strict conservation of the glutamate between the twoCell 163, 607–619groups may reflect its role in stabilizing
the oxocarbenium intermediate that
forms upon nicotinamide dissociation
from ADP-ribose during the catalytic cy-
cle (Yates et al., 2006). Our structure indicates that Tse6 residues
differ from those of both mART groups at each position involved
in NAD+ binding, including the placement of a non-acidic residue
at position 3 (Gln413) (Figure 2B). Nonetheless, the pocket lined
by these residues is the principal site of Tsi6 binding, suggesting
its importance for the toxic activity of Tse6. In total, our structural
analyses suggest that Tse6282-CT is a mART fold enzyme with
unique substrate binding and catalytic motifs.
Tsi6 assumes an all a-helical fold that arranges into a four-helix
bundle (Figure 2A). A search of the PDB indicates that Tsi6
shares structural similarity with several proteins of unknown
function including Nmul_A1745 from Nitrosospira multiformis (Z
score, 10.4; Ca RMSD of 2.2 A˚ over 86 equivalent positions)
and PA2107 from P. aeruginosa (Z score, 9.5; Ca RMSD of
2.1 A˚ over 82 equivalent positions). The Tse6282-CT–Tsi6 interac-
tion involves extensive contacts between a3 of Tsi6 and the
putative NAD+ binding pocket of Tse6282-CT. Interface analysis
indicates that complex formation between Tse6282-CT and Tsi6
buries 1,348 A˚2 of solvent-accessible surface area. Isothermal
titration calorimetry (ITC) measurements yielded a dissociation
constant of 31 nM for the complex (Figure S1B).
To identify the conformational changes within Tsi6 required for
inhibition of Tse6 activity, we determined the 1.9 A˚ crystal struc-
ture of Tsi6 in isolation (Table S1). Overall, the structure of free
Tsi6 does not differ significantly from that of Tsi6 in complex
with Tse6282-CT (Ca RMSD of 0.4 A˚) (Figure S1C). This includes
amino acid side chains of Tsi6 involved in the interaction with
Tse6282-CT, with the notable exception of Lys62, which rotates
approximately 120 around Cb to form a hydrogen bond with
the putative NAD+ binding residue at position 3, Gln413 (Fig-
ure 2C). Taken together, our structural data suggest that Tsi6, October 22, 2015 ª2015 Elsevier Inc. 609
CE
m/z
665 120 125 130 555 560 565
Tse6 282-CT
Tse6 282-CT + Tsi6
NAD+ Nicotinamide ADP-ribose
A
eEF2
ExoA
B
eEF2
Tse6 282-CT
D
100 200 300 400
[enzyme, pM]
0
NA
D+
 
co
ns
um
pt
ion
 
(nM
/m
in x
 10
4 )
Tse6 282-CT
Tse6 282-CT + Tsi6
k
cat = (11.9 ± 1.0) x 104 min-1
0
1.0
2.0
3.0
4.0
5.0
[enzyme, pM]
Tse6 282-CT
Tse6 282-CT + Tsi6
k
cat = (5.9 ± 0.4) x 104 min-1N
AD
P+
 
co
ns
um
pt
ion
 
(nM
/m
in x
 10
4 )
0 250 500 750 1000
0
1.5
3.0
4.5
6.0
7.5
pa
ren
tal
tsi6
–
D4
0
50
100
NAD+
NADP+
Re
lat
ive
 ce
llu
lar
 [N
AD
(P)
+
]
(%
, n
orm
aliz
ed
 to
 Δr
et
S )
0
50
100
Re
lat
ive
 ce
llu
lar
 [N
AD
(P)
+
]
(%
, n
orm
aliz
ed
 to
 ve
cto
r c
on
tro
l)
F GNAD+ NADP+
125
75
25
660 670
m/z
665 120 125 130 555 560 565660 670
-
Tsi
6
+T
si6
-
Tsi
6
+T
si6
Tse6 282-CT
75
25
Figure 3. Tse6 Is an NAD(P)+ Glycohydro-
lase Toxin
(A) mART toxins possess open active sites that
allow for docking of their protein targets. Co-
crystal structure of P. aeruginosa ExoA and eu-
karyotic elongation factor 2 (eEF2) from Jørgensen
et al. (2005). The diphthamide moiety of eEF2 that
is ADP-ribosylated by ExoA is shown in pink as a
stick representation.
(B) Structural superposition of Tse6282-CT with
ExoA predicts a steric clash with eEF2. The clash
occurs through the conserved [K/R]STxxPxxDxx
[S/T] motif of Tse6 (red).
(C and D) Tse6282-CT exhibits NAD(P)
+ glycohy-
drolase activity. Rate of NAD+ (C) and NADP+ (D)
consumption by purified Tse6282-CT in the pres-
ence and absence of Tsi6. Each enzyme concen-
tration was assayed in triplicate, and error bars
represent ± SD.
(E) Mass spectra of the products generated by
Tse6-catalyzed breakdown of NAD+. Peaks cor-
responding to nicotinamide ([M+H]+, m/z = 123.1)
and ADP-ribose ([M-H], m/z = 558.3) were
identified in the reaction containing Tse6282-CT,
whereas NAD+ ([M+H]+,m/z = 664.4) was identified
in the reaction containing the Tse6282-CT–Tsi6
complex.
(F) NAD(P)+ levels in E. coli cells expressing
Tse6282-CT (Tsi6) or co-expressing Tse6282-CT
and Tsi6 (+Tsi6) relative to empty vector. Cellular
NAD(P)+ levels were assayed 60 min after induc-
tion of Tse6282-CT expression.
(G) Relative NAD(P)+ levels in the indicated
P. aeruginosa strains 45 min after induction of Tsi6
degradation. Strains correspond to those used in
Figure 1C. Error bars represent ± SD (n = 3).
See also Figure S2 and Tables S2 and S3.inhibits the activity of Tse6 through direct occlusion of its puta-
tive NAD+ binding site.
Tse6 Exhibits NAD(P)+ Glycohydrolase Activity
The structure of Tse6282-CT implies that the toxin may exert its ef-
fects within recipient cells via mono-ADP-ribosylation of an un-
known bacterial protein. An important feature of characterized
mART enzymes that facilitates their transferase activity is an
open active site that allows docking of the acceptor protein.
This concept is exemplified by the co-crystal structure of
P. aeruginosa ExoA in complex with eukaryotic elongation factor
2 (Figure 3A) (Jørgensen et al., 2005). However, structural super-
position of Tse6282-CT with ExoA predicts a steric clash between
Tse6282-CT and a proteinaceous ADP-ribose acceptor (Fig-
ure 3B). Interestingly, the structural element of Tse6282-CT that
prohibits accommodation of a high-molecular-weight acceptor
is comprised of a motif conserved among Tse6 orthologs ([K/
R]STxxPxxDxx[S/T]), implying that this region is important for
Tse6 function (Zhang et al., 2012). Consistent with these data, in-
cubation of purified Tse6 with P. aeruginosa or E. coli cell lysates
containing 32P-NAD+ did not lead to observable transfer of 32P-
ADP-ribose to a protein target (data not shown).610 Cell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc.Given the limited accessibility of the Tse6 active site, we hy-
pothesized that the protein might instead function as an NAD+
glycohydrolase. Although it is less common within the mART su-
perfamily of enzymes, NAD+ glycohydrolase activity has been
observed for the SPN toxin of Streptococcus pyogenes (Ghosh
et al., 2010). To test our hypothesis that Tse6 is an NAD+ glyco-
hydrolase enzyme, we performed kinetic analyses of NAD+ con-
sumption by Tse6282-CT. Whereas mART enzymes exhibit only
low levels of NAD+ hydrolysis (<10 min1), we found that purified
Tse6282-CT catalyzes NAD
+ breakdown at a rate of approximately
1.23 105 min1 (Figure 3C) (Ghosh et al., 2010). This activity was
reduced to background by the addition of 1.5 molar equivalents
of Tsi6 to the reactionmixture, suggesting NAD+ degradation is a
physiologically relevant activity of the toxin. Given the structural
similarity between NAD+ and its phosphorylated derivative
NADP+, we also tested the ability of Tse6282-CT to consume
NADP+. Breakdown of this dinucleotide occurred at a compara-
ble rate (6.0 3 104 min1), suggesting that Tse6 degrades both
NAD+ and NADP+ (NAD(P)+) (Figure 3D).
Rather than hydrolytically cleaving their substrates, some
NAD+-degrading enzymes generate a cyclic product that is a
characterized signaling molecule in eukaryotes (Guse, 2000).
The fluorescence assay we employed does not distinguish be-
tween cyclized and non-cyclized forms of ADP-ribose, thus we
used mass spectrometry (MS) to analyze the reaction products
of Tse6 and NAD+. Nicotinamide and ADP-ribose were the only
detectable products, defining Tse6 as an NAD(P)+-glycohydro-
lase enzyme (Figure 3E).
Tse6 Induces Bacteriostasis by Depleting Cellular
NAD(P)+ Levels
Our biochemical data show that Tse6 rapidly hydrolyzesNAD(P)+
in vitro; however, it is possible that we observe this activity due to
the absence of an appropriate ADP-ribose acceptor molecule.
To address this possibility, we expressed Tse6282-CT in E. coli
and measured endogenous NAD(P)+ levels. Upon induction of
Tse6282-CT expression, we found that E. coli cells contained
vastly reduced cellular concentrations of NAD+ and NADP+ rela-
tive to the vector control (Figure 3F). Co-expression with Tsi6
restored NAD(P)+, indicating that the loss of the dinucleotides
is a direct consequence of Tse6282-CT activity.
Next, we sought tomeasure the influence of endogenous Tse6
on NAD(P)+ levels in intoxicated P. aeruginosa cells. In agree-
ment with our findings in E. coli, intracellular intoxication caused
by depletion of Tsi6 led to a profound decrease in NAD(P)+ (Fig-
ure 3G). The precise measurement of Tse6-catalyzed NAD(P)+
depletion during intercellular intoxication is complicated by
high background levels of the dinucleotides derived from donor
cells, which as intoxication of recipient cells proceeds, constitute
an increasingly large proportion of the total cellular population.
To partially overcome this, we examined a time point at which
recipient cells have begun to experience intoxication, but are
not yet depleted from the population. Comparing total NAD+
levels in conjunction with donor and recipient colony-forming
units (CFU) to a reference experiment, we confirmed a significant
reduction in NAD+ within recipient cells (Figure S2). Based on
these findings, we propose that the toxicity elicited by Tse6 is
due to depletion of cellular NAD(P)+ pools.
Tse6 Participates in a Five-Protein Complex Containing
Elongation Factor Tu
Bioinformatic analyses predict that Tse6 is a PAAR domain-con-
taining integral membrane protein (Figure 1B). To test whether
Tse6 resides in membranes, we generated a P. aeruginosa
strain producing a functional fusion of Tse6 to the vesicular
stomatitis virus glycoprotein epitope from the native tse6 locus
(tse6-V) (Figure S3A). Western blot analysis of the soluble and
membrane fractions of this strain revealed that despite high-
confidence prediction of transmembrane domains within Tse6,
the majority of the protein is soluble (Figure 4A). Based on
structural studies of PAAR domains in complex with VgrG-like
chimeras, it has been speculated that effectors containing
this domain interact with VgrG proteins (Shneider et al., 2013).
We hypothesized that Tse6 could be solubilized within donor
cells by virtue of association with VgrG1 via its PAAR domain.
Indeed, in the absence of VgrG1, we observed significant repar-
titioning of Tse6 to the membrane fraction of cells. Tse6
remained soluble in a strain lacking tssM1, indicating that
the localization of the toxin is not generally sensitive to T6
function.Motivated by the finding that Tse6 is a soluble protein in the
presence of VgrG1, we used co-immunoprecipitation to probe
for a physical interaction between the proteins. Surprisingly,
this led to the identification of a putative complex containing
Tse6, Tsi6, VgrG1, PA0094, and translation elongation factor
Tu (EF-Tu) (Figure 4B). PA0094 is a member of a recently
described group of effector-specific accessory factors that facil-
itate delivery of their cognate effectors (Alcoforado and Coulth-
urst, 2015). Henceforth, we refer to PA0094 as effector-associ-
ated gene with tse6 (EagT6).
The identification of EF-Tu in a complex containing Tse6 was
unexpected. This conserved bacterial protein is a GTPase that
delivers newly charged aminoacyl-tRNA molecules to the ribo-
some during translation elongation (Voorhees and Ramak-
rishnan, 2013). Interactions between T6 effectors and essential
bacterial proteins have not been described; therefore, we
decided to probe the functional significance of this observation.
To test whether Tse6 and EF-Tu interact directly, we initiated ex-
periments to evaluate P. aeruginosa EF-Tu (EF-TuPA) binding to
the soluble region of Tse6 (Tse6222-CT) in vitro. Interestingly, dur-
ing the course of this work, we noted Tse6222-CT associates with
E. coli EF-Tu (EF-TuEC), which is 88% identical to EF-TuPA. Puri-
fication of N-terminal Tse6 truncations narrowed the region
responsible for EF-Tu binding to the last 165 amino acids of
the toxin (Figure 4C). Since EF-Tu does not bind the glycohydro-
lase domain of Tse6 (residues 282-CT), we reasoned that the
interaction with EF-Tu requires amino acids 265–282 of the toxin.
Despite considerable sequence divergence from P. aeruginosa
Tse6, orthologs of the toxin from P. putida and P. syringae also
co-purified with EF-TuEC (Figures S3B and S3C).
Next, we measured the binding affinity of Tse6265-CT to EF-
TuEC and EF-TuPA using ITC. Guanosine triphosphate (GTP) hy-
drolysis by EF-Tu is coupled to significant structural changes in
the protein; therefore, we investigated both GTP- and GDP- (EF-
TudGDP) bound conformations of the molecule (Clark and Ny-
borg, 1997). In line with our purification results, we found that
Tse6265-CT interacts tightly with both EF-Tu
EC
dGDP (Kd =
81 nM) and EF-TuPAdGDP (Kd = 23 nM) (Figures S3D and S3E).
Application of the antibiotic Aurodox, which locks EF-Tu into
its GTP-bound conformation, reduced the affinity for Tse6 by
approximately 10-fold (Figure S3F) (Vogeley et al., 2001). In sum-
mary, these data indicate that Tse6 binds directly to the GDP
form of EF-Tu within a larger, multiprotein complex.
Structure of the Tse6-EF-Tu Complex
Though all cells require NAD(P)+, the process of translation
does not rely on these co-factors. Thus, the significance of
Tse6 interaction with EF-Tu was not apparent. As a first step
toward defining the relevance of the Tse6-EF-Tu complex, we
determined the 3.5 A˚ crystal structure of Tse6265-CT bound to
EF-TuPAdGDP (Figure 4D; Table S1).
Overall, the structure of Tse6265-CT is highly similar toTse6282-CT
(Ca RMSD of 0.7 A˚). The most striking divergence between the
two structures is the ordering and 60 hinge-like movement of
the [K/R]STxxPxxDxx[S/T] motif-containing loop, henceforth
referred to as the Tse6 activation loop. This results in a 15-A˚
displacementofAsp396 that directs its sidechain into theputative
NAD(P)+ binding site (Figure 4E). Asp396 is the sole invariantCell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc. 611
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acidic residue among Tse6 orthologous proteins, leading us
to postulate that it serves a role analogous to the conserved
glutamic acid at position 3 within the DT and CT mART families
(Figure S4) (Zhang et al., 2012). Consistent with this hypothesis,
purified Tse6282-CT
D396A displayed approximately 225-fold
reduced NAD(P)+ glycohydrolase activity relative to the wild-
type protein, and a P. aeruginosa strain producing Tse6D396A
from the native tse6 locus did not exhibit Tse6-based intercellular
intoxication (Figures 4F and 4G).
In accordance with our Tse6 truncation studies, interaction
with EF-TuPA is mediated by residues immediately N-terminal
to the toxin domain (residues 265–291). This basic segment
forms two a helices (a0 and a1) that engage in numerous salt
bridges with acidic side chains on the GTPase domain (G
domain) of EF-TuPA. Interestingly, the EF-TuPA residues involved
in this interaction are found on helix D, which functions as the key
interaction site for both the guanine exchange factor EF-Ts and
the ribosome (Figure 4H) (Kawashima et al., 1996).
Interaction with EF-Tu Is Required for the Delivery of
Tse6 into Recipient Cells
Our structure of Tse6265-CT–EF-Tu
PA shows that a spatially
confined cluster of electrostatic interactions facilitates binding
of the proteins (Figures 5A and 5B). We reasoned that this inter-
action mechanism might afford an opportunity to dissect the
functional significance of the interaction via site-directed muta-
genesis. A non-conserved leucine residue (Leu270) was identi-
fied within the patch of basic amino acids on a0 that mediate
EF-Tu binding (Figure 5C). We postulated that an acidic residue
substituted at this position would disrupt charge complemen-
tarity between the proteins. As predicted, Tse6222-CT
L270E did
not co-purify with EF-TuEC, whereas variants containing a
more conservative substitution at this site (L270A) or an analo-
gous substitution on the opposite face of a0 (A268E) retained
EF-TuEC binding (Figure 5D).
Encouraged by our in vitro data, we next generated a
P. aeruginosa strain expressing Tse6L270E-V from the native
tse6 locus. An immunoprecipitation and growth competition
experiment utilizing this strain showed that Tse6L270E-V displays
a specific defect in EF-Tu interaction and is unable to intoxicate
recipient cells (Figures 5E and 5F). We conclude that association
with EF-Tu is essential for Tse6-based toxicity.
Tse6-based intercellular intoxication can be viewed as a num-
ber of discrete processes. We considered the involvement in and(B) Silver-stained SDS-PAGE analysis of proteins enriched by anti-VSV-G immun
The labels indicate the identities of proteins that specifically co-precipitate with T
Tse6 form a high-molecular-weight complex that is resistant to heat and SDS de
(C) A 17-amino-acid segment of Tse6 mediates interaction with EF-Tu. Coomassi
expressed with Tsi6 and assessed for co-purification with endogenous EF-TuEC
(D) Overall structure of the Tse6265-CT–EF-Tu
PA complex. Secondary structure el
(E) The Tse6 activation loop harbors Asp396 and rotates toward the active si
Tse6282-CT–Tsi6 structure. Dots denote a disordered segment (amino acids 400-
(F) Tse6282-CT D396A exhibits significantly reduced NAD(P)
+ glycohydrolase acti
D396A.
(G) Asp396 is critical for Tse6-based intercellular toxicity. Growth competition e
Donor and recipient strains were mixed 1:1, grown for 24 hr on solid media, and
(H) Helix D of EF-Tu is the site of interaction for both Tse6265-CT (left) and the guani
See also Figures S3 and S4and Tables S1–S3.requirement for EF-Tu in (1) the stability of Tse6, (2) the enzy-
matic activity of Tse6, (3) Tse6 export from donor cells, and (4)
entry of Tse6 into recipient cells. Since Tse6L270E is present at
equal concentrations as the wild-type protein, we ruled out a
requirement for EF-Tu in Tse6 stability. Our biochemical data
show that the catalytic domain of Tse6 degrades NAD+ rapidly,
at a rate consistent with a known cytotoxic NAD+ glycohydrolase
enzyme (Ghosh et al., 2010). Therefore, one possibility is that
residues N-terminal to the toxin domain are auto-inhibitory and
that EF-Tu binding to this region relieves this inhibition. Indeed,
the activation loop of Tse6 differs significantly in position be-
tween the Tse6282-CT–Tsi6 and Tse6265-CT–EF-Tu
PA structures,
suggesting that either EF-Tu induces a conformational change
in the toxin or immunity protein binding excludes this loop from
the active site (Figure 4E). We found that a purified Tse6 variant
that includes the EF-Tu binding region (Tse6222-CT) catalyzes
NAD+ hydrolysis at a rate indistinguishable to the toxin domain
alone (Figure 5G). Furthermore, the activity of this protein was
unaffected by the addition of excess EF-TuPA.
Next, we considered the possibility that association of Tse6
with EF-Tu is required for export of the toxin from donor cells.
However, we found that both cellular and extracellular levels of
Tse6L270E-V are similar to the wild-type protein (Figure S5).
These experiments further showed that unlike the Hcp-associ-
ated effector Tse1, Tse6 accumulation in the exo-proteome of
P. aeruginosa is only partially dependent on H1-T6SS function.
The significance of this is not yet understood; however, strains
lacking the T6S ATPase ClpV1 or the core integral membrane
protein TssM1 yielded similar results.
Since interaction with EF-Tu is dispensable for Tse6 catalytic
activity and export, we deduced that interaction with the transla-
tion factor must be required for Tse6 to reach the cytoplasm of
recipient cells. In further support of this contention, we found
Tse6L270E-V is as active in intracellular intoxication triggered by
Tsi6 depletion as the wild-type protein (Figure 5H). Together
with our findings that Tse6L270E-V is incapable of Tse6-based
intercellular intoxication despite its unencumbered transit of
the T6SS, these data indicate that interaction with EF-Tu grants
Tse6 access to the cytoplasm of recipient cells.
Ultrastructure of a T6 Effector-VgrG Complex
VgrG is thought to serve as the T6S protein that pierces the outer
membrane of recipient cells, granting its bound cognate effec-
tor(s) access to the periplasm of target cells (Silverman et al.,oprecipitation from P. aeruginosa strains encoding Tse6 (parental) and Tse6-V.
se6-V as determined by MS. In addition to their monomeric forms, VgrG1 and
naturation.
e-stained SDS-PAGE analysis of purified Tse6 truncations. All truncations were
.
ements involved in the interaction are labeled.
te of Tse6 in the Tse6265-CT –EF-Tu
PA structure relative to its position in the
408) of Tse6282-CT that was not modeled.
vity. Rate of NAD+ (left) and NADP+ (right) consumption by purified Tse6282-CT
xperiments between the indicated P. aeruginosa donor and recipient strains.
differentiated using blue/white screening.
ne exchange factor EF-Ts (right). In all panels, error bars represent ± SD (n = 3).
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Figure 5. Interaction with EF-Tu Is Required for Tse6-Based Intercellular Toxicity
(A and B) An electrostatic patch mediates interaction between EF-Tu and Tse6265-CT. Electrostatic surface representation of EF-Tu
PA (A) and Tse6265-CT (B).
Residues participating in the interaction are labeled and outlined in black.
(C) Close-up view of the Tse6265-CT –EF-Tu
PA interaction. Secondary structure elements referred to in the text are labeled.
(D and E) An L270E variant of Tse6 does not interact with EF-TuEC or EF-TuPA. (D) Coomassie-stained SDS-PAGE analysis of purified Tse6265-CT variants. All
variants were expressed with Tsi6 and assessed for their ability to co-purify with endogenous EF-TuEC. (E) Silver-stained SDS-PAGE analysis of proteins enriched
by anti-VSV-G immunoprecipitation from P. aeruginosa strains encoding Tse6-V (parental) and Tse6-VL270E. Enriched low-molecular-weight proteins (EagT6 and
Tsi6) not shown.
(F) Tse6 requires interaction with EF-Tu to intoxicate recipient cells. Outcome of growth competition experiments between the indicated P. aeruginosa donor
strains and a parental (DretS) or Tse6-susceptible (Dtse6 Dtsi6) recipient. The competitive index is calculated as the change (final/initial) in ratio of donor to
recipient CFU.
(G) Interaction with EF-TuPA does not enhance NAD+ glycohydrolase activity of Tse6222-CT. Reactions were performed using 500 pM Tse6222-CT in the presence or
absence of 1 mM EF-TuPA.
(H) Interaction with EF-Tu is not required for Tse6-based intracellular intoxication. NAD+ levels in the indicated P. aeruginosa strains 45 min after induction of Tsi6
degradation (top). Patches of the indicated P. aeruginosa strains grown for 24 hr at 37C under Tsi6 depletion-inducing (+IPTG) conditions (bottom). The parental
strain is the same as in Figure 1C. Error bars represent ± SD (n = 3).
See also Figure S5and Tables S2 and S3.
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Figure 6. Two Conformations of the Tse6 Secretory Particle Revealed by Electron Microscopy
(A and B) Addition of detergent dissociates EagT6 from the Tse6 secretion particle and causes a conformational change. (A) Coomassie-stained SDS-PAGE
analysis and (B) representative class averages of purified Tse6-containing complex in the presence and absence of 0.03% b-D-dodecylmaltopyranoside.
(C) 3D density map and molecular fitting of the Tse6-Tsi6-VgrG1-EagT6-EF-TuPA complex. The identity of each subunit is indicated. The model for Tse6PAAR was
generated using Phyre (Kelley and Sternberg, 2009).
(D) Tse6 requires EagT6 for intracellular accumulation. Western blot analysis of Tse6 levels in the indicated P. aeruginosa strains. RNA polymerase (RNAP) is used
as a loading control.
(E) 3D density map and molecular fitting of the detergent-bound Tse6–Tsi6–VgrG1–EF-TuPA complex. Scale bars, 20 nm.
See also Figures S6 and S7and Tables S2 and S3.2012). The PAAR domain of effectors associates with the tip of
VgrG; however, the placement of additional effector domains,
as well as accessory proteins, in this particle is not known
(Shneider et al., 2013). To gain insight into the topology of an
effector-loaded VgrG complex, we examined purified C-termi-
nally octa-histidine-tagged Tse6 in complex with Tsi6, VgrG1,
EagT6, and EF-TuEC using negative-stain electron microscopy
(EM) (Figures 6A and 6B, left).Analysis of 12,000 single particles permitted the calculation of
a 3D map of the complex resolved to 22 A˚ (Figures 6C and S6A–
S6D). VgrG proteins have a characteristic structure that was
readily apparent within the map (Shneider et al., 2013). Fortu-
itously, the unpublished X-ray crystal structure of P. aeruginosa
VgrG1 is available in the PDB (PDB: 4MTK); the location of this
trimeric assembly in our structure was unambiguous. For esti-
mating the placement of Tse6, Tsi6, and EF-Tu, we were ableCell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc. 615
to utilize our assorted high-resolution structures of these pro-
teins to produce a ternary complex that largely conformed to re-
gions of density found near the end of the complex predicted to
initiate contact with recipient cells. An additional constraint on
the location of Tse6 is its PAAR domain, which could bemodeled
with high confidence bound to the tip of VgrG1 (Figure 6C). The
91 residues connecting Tse6PAAR to the first residue included in
our modeled ternary complex (residue 265) are predicted to form
a transmembrane helix, followed by a disordered glycine-rich
span (not modeled). Ni-NTA-nanogold labeling of the C-terminal
His8-tag of Tse6 provided support for our placement of this
linchpin protein within the complex (Figure S6E).
The positions of VgrG, Tse6, Tsi6, and EF-TuPA left a protrud-
ing region of density surrounding the PAAR domain of Tse6
unoccupied. We postulated that this region of the map corre-
sponds to EagT6. The structure of EagT6 was determined in a
high-throughput X-ray crystallography project and made pub-
licly available. The domain-swapped homodimeric protein bears
a distinctive horseshoe configuration that we placed in this unoc-
cupied density (Figures 6C and S7A). In this configuration, EagT6
would be predicted to bind Tse6PAAR and its buttressing hydro-
phobic segments. To test this prediction, we performed co-puri-
fication experiments of the proteins in E. coli. In contrast to the
complex isolated with full-length toxin, Tse6222-CT did not co-pu-
rify with EagT6 (Figure S7B). Although the X-ray crystal structure
of EagT6 does not fully agree with the calculated map in this re-
gion, these data provide biochemical support for our placement
of EagT6 in proximity to the N-terminal domains of Tse6.
To garner additional insight into EagT6 function, we probed
the capacity of P. aeruginosa DeagT6 to intoxicate Tse6-sensi-
tive recipient cells. This strain failed to elicit Tse6-based toxicity,
but retained the capacity to intoxicate recipients using another
H1-T6S effector (Figure S7C). EagT6 associates with a region
of Tse6 rich in transmembrane domains, suggesting that the
accessory factor could act as a chaperone for the toxin. As pre-
dicted for substrate-chaperone systems, we found that accumu-
lation of Tse6 is markedly diminished by the absence of EagT6
(Figure 6D). Genetic complementation of this phenotype was
achieved with ectopic expression of eagT6. Taken together
with the findings of Alcoforado and Coulthurst (2015) pertaining
to a EagT6-related protein in Serratia, we propose that EagT6
functions as a Tse6-specific chaperone.
Tse6 is a transmembrane protein; thus, its transport between
cells likely requires shielding of its hydrophobic domains. Based
on its orientation and position relative to Tse6 in our model,
we posited that EagT6might chaperone Tse6 by shielding its hy-
drophobic segments from aqueous mediums during intercellular
transport. In support of this hypothesis, EagT6 dissociates from
the effector complex in the presence of detergent (Figure 6A,
right). To gain structural insight into the consequence of EagT6
release, we examined the Tse6 particle depleted of this protein
by negative-stain EM and single-particle reconstruction (Fig-
ure 6B, right). Analysis of 11,000 particles permitted the calcula-
tion of a 3Dmap of the complex resolved to 19 A˚ (Figures 6E and
S6F–S6J). Remarkably, we observed a 40 A˚ movement of the
EF-Tu–Tse6265-CT–Tsi6 sub-complex from VgrG-Tse6PAAR. The
localization of Tse6265-CT within the displaced density was veri-
fied by Ni-NTA-nanogold labeling (Figure S6K). Accompanying616 Cell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc.this reorganization, we observed a region of unoccupied density
in proximity to the predicted site of the hydrophobic segments of
Tse6. Given the capacity of detergent to compete for EagT6
binding to the complex, we hypothesize that ordered detergent
molecules bound to the hydrophobic domains of Tse6 occupy
this density.
The significance of Tsi6 and EF-Tu within the effector complex
is not understood. The toxicity conferred by depletion of Tsi6 from
donor cells shows that the catalytic domain of Tse6 is present in
the cytoplasm and is in complex with Tsi6 prior to export by the
H1-T6SS. Therefore, EF-Tu also likely interactswith the toxin prior
to export. If these proteins do not dissociate from the toxin during
transit, the structures we obtained would represent the secreted
complex. Alternatively, Tsi6 and EF-Tu could be removed during
secretionand re-engage thecomplex in thecytoplasmof recipient
cells. In this scenario, the complex we isolated would represent
that found in recipient cells with immunity. In total, our ultrastruc-
tural analyses of the Tse6 secretory particle define the architec-
ture of an effector-loaded VgrG and suggest a mechanism for
deployment of a membrane-associated toxin (Figure 7).
DISCUSSION
Wehave discovered that Tse6 intoxicates recipient cells by cata-
lyzing the hydrolytic removal of the nicotinamide moiety from
NAD+ and NADP+. This mechanism has not been described for
an interbacterial toxin, but it is consistent with the general obser-
vation that T6 effectors act on target molecules that are both
essential and highly conserved among bacteria (Russell et al.,
2014). The consequence of NAD(P)+ degradation by Tse6 is sta-
sis in most cells, rather than death. The relative benefit(s) of in-
hibiting the growth of target cells is not yet understood; however,
the H1-T6SS Tse2 toxin also induces stasis in recipients (Li et al.,
2012). In instances of self-intoxication, the exchange of bacterio-
static toxins could promote the formation of persister cells. A
non-mutually exclusive possibility is that when delivered within
an effector cocktail, bacteriostatic and bacteriocidal toxins act
synergistically.
The requirement for NAD(P)+ extends to all forms of life, raising
the possibility that Tse6, and related proteins exported by the
T6SS, could intoxicate archaeal and eukaryotic cells. The SPN
toxin ofS. pyogenes provides precedent for the action of a bacte-
rialNAD+glycohydrolaseagainst aeukaryotic target, although this
is a structurally distinct toxin that utilizes pores introduced by
Streptolysin O to gain entry into host cells (Madden et al., 2001;
Smith et al., 2011). TheH3-T6SSofP. aeruginosahasbeen shown
todeliver a phospholipaseD toxin tobothbacterial andeukaryotic
cells, implying that there is not a fundamental barrier to inter-
domain targeting of effectorsby this bacterium (Jianget al., 2014).
To our knowledge, the requirement for a housekeeping protein
in the function of a T6S effector has not previously been
observed. Likely owing to the central role of EF-Tu in translation,
tufA, which encodes EF-Tu, is a slowly evolving bacterial gene
(Lathe and Bork, 2001). Thus, if the role of the Tse6 interaction
with a cellular housekeeping protein is to grant the toxin access
to recipient cells as our data suggest, EF-Tu would allow the
toxin to target phylogenetically diverse bacteria. The high con-
centration of EF-Tu within cells could also contribute to a wide
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Figure 7. Proposed Model for Tse6 Transport by the T6S Apparatus
The configuration of the Tse6 particle subunits in donor and recipient cells
represent those determined in this study in the absence and presence of
detergent, respectively. A representative EM class average for each is pro-
vided for reference. In the donor cell, Tse6 and associated proteins are bound
to the T6S sheath complex (gray; PDB: 3J9O) (Clemens et al., 2015). The T6
trans-envelope complex (composed of TssL, M, and J) is schematized to
approximate its recently determined EM structure (Durand et al., 2015),
whereas the T6 baseplate-like assembly is depicted in filled gray. In the model,
donor cell EF-Tu (light blue) and Tsi6 disengage from the Tse6 secretion
particle upon export from the donor cell. Upon crossing the outer membrane
(OM) of the recipient cell, EagT6 dissociation frees the hydrophobic domains of
Tse6 (yellow rectangles) for incorporation into the recipient inner membrane
(IM). Recipient cell EF-Tu (dark blue) facilitates transfer of the NAD(P)+ gly-
cohydrolase domain into the recipient cell cytoplasm by an unknown mech-
anism. Several other possibilities consistent with all available data are not
presented. Most notably, donor-cell-derived EF-Tumay be exported as part of
the secretion particle and facilitate Tse6 delivery into recipient cells, or donor-
cell-derived EF-Tu may be excluded from the secretion complex.
See also Tables S2 and S3target range for Tse6, as there would be more tolerance for
weakened association between the two proteins driven by EF-
Tu sequence divergence.
Although the site of Tse6 binding to EF-Tu would preclude
binding of the translation factor to EF-Ts, it is unlikely that Tse6
affects translation (Kawashima et al., 1996). We find Tse6 pre-
sent at low levels in P. aeruginosa; therefore, the yet lower levelswithin recipient cells would not sequester a functionally signifi-
cant portion of EF-Tu. Indeed, there is growing evidence that
the large pool of EF-Tu is exploited for multiple purposes within
bacteria, including P. aeruginosa (Balasubramanian et al., 2008;
Barel et al., 2008; Defeu Soufo et al., 2010; Kunert et al., 2007;
Mohan et al., 2014). Barbier et al. (2013) have found that EF-
TuPA is posttranslationally modified by trimethylation at Lys5.
These authors also found that this form of the protein localizes
to the cell surface, where it mediates interactions with airway
epithelial cells. Whether EF-Tu is actively secreted to the cell sur-
face or if its presence there is a consequence of cell lysis was not
determined. It is worth noting that the high concentration of EF-
Tu present in culture supernatants through T6-independent
mechanisms precluded measurement of the contribution of T6
to EF-Tu export in our study.
Given the changing chemical and physical environments that
necessarily accompany translocation across multiple mem-
branes, it is without doubt that effectors delivered intercellularly
assume multiple states en route. We have captured just two of
these for a T6S effector. Tse6 is the hub of a multi-protein com-
plex in our structures; however, our biochemical data show that
it need not interact with any of these proteins in order to catalyze
NAD(P)+ degradation. This leaves many open questions, in-
cluding how does EF-Tu facilitate Tse6 translocation into recip-
ient cells? From our current data, we cannot determine whether
EF-Tu derived from donor cells, recipient cells, or both is critical
for Tse6 activity. One appealing model consistent with our data
holds that Tse6 is delivered to the target cell periplasm, where-
upon EagT6 is released and the exposed transmembrane seg-
ments of the toxin spontaneously insert into the inner membrane.
At this point, translocation of residues N-terminal to the toxin
domain and ensuing EF-Tu-binding could serve as a molecular
ratchet that favors passage of the remaining toxin domain into
the cytoplasm. Interestingly, the EF-Tu binding domain of Tse6
is rich in basic residues, a property of many known cell-pene-
trating peptides (Bechara and Sagan, 2013).
While this study provides two snapshots of interbacterial pro-
tein transport, it also highlights the challenges in understanding
this intricate, multi-step process. The Tse6 particle we describe
may provide a tractable system for the characterization of addi-
tional secretory intermediates. A complete understanding of
toxin entry into recipient cells could define novel routes for the
delivery of antimicrobials.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
All P. aeruginosa strains generated were derived from the sequenced strain
PAO1 (Stover et al., 2000). P. aeruginosa mutants and chromosomal fusions
were generated by allelic exchange as described previously (Hood et al.,
2010). E. coli strains DH5a, BL21(DE3) pLysS, and SM10 were used for plasmid
maintenance,geneexpression, andconjugative transfer, respectively.Adetailed
list of strains and plasmids used in this study can be found in Tables S2 and S3.
Crystallization and Structure Determination
Details for the crystallization of Tse6282-CT–Tsi6, Tsi6, and Tse6265-CT–EF-Tu are
described in the Supplemental Experimental Procedures. The structures of
Tse6282-CT–Tsi6 and Tsi6 were solved by Se-SAD. The Tse6265-CT-
EF-Tu structure was solved by molecular replacement using EF-TuECdGDP
(PDB: 1EFC) as a search model. Details for structure determination and modelCell 163, 607–619, October 22, 2015 ª2015 Elsevier Inc. 617
refinement are described in the Supplemental Experimental Procedures
(Table S1).
Biochemical Assays
Hydrolysis rates of NAD(P)+ by Tse6 were measured using a fluorescence
endpoint assay as described previously (Johnson and Morrison, 1970). Deter-
mination of relative NAD+ and NADP+ levels from cell lysates was performed
using the NAD/NADH-Glo and NADP/NADPH-Glo bioluminescence assays,
respectively, as per the instructions of the manufacturer (Promega). Details
can be found in the Supplemental Experimental Procedures.
Bacterial Competition Assays
Intraspecific competition assays between P. aeruginosa strains were per-
formed as previously described (Whitney et al., 2014). Briefly, overnight cul-
tures of P. aeruginosa strains were mixed in a 1:1 ratio and spotted onto
0.2-mm nitrocellulose membranes overlaid on a 3% agar Luria broth no-salt
plate. Competitive indices were calculated by enumerating donor/recipient
CFU after 24 hr of growth at 37C. All competitive indices were adjusted by
the donor/recipient ratio in the initial inoculum. Recipient strains express the
lacZ gene from a neutral phage attachment site to enable their differentiation
from unlabeled donor via blue/white screening.
Electron Microscopy and Image Analysis
Protein samples were negatively stained with uranyl formate (SPI Supplies/
Structure Probe) and imaged using a JEOL1400 microscope equipped with
a LaB6 cathode operated at 120 kV. Images were recorded at a magnification
of 50,0003 on a 4k 3 4k CMOS camera F416 (TVIPS). Data analysis and
further processingwas done in SPARX (Hohn et al., 2007). Details can be found
in the Supplemental Experimental Procedures.
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